mannose has been researched along with 2019 Novel Coronavirus Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 14 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlén, G; Ambikan, AT; Asghar, M; Benfeitas, R; Gupta, S; Krishnan, S; Mikaeloff, F; Neogi, U; Nikouyan, N; Nordqvist, H; Nowak, P; Odeh, A; Ponnan, SM; Rodriguez, JE; Saccon, E; Sällberg, M; Sönnerborg, A; Sperk, M; Svensson-Akusjärvi, S; Treutiger, CJ; Végvári, Á; Vesterbacka, J | 1 |
| Allen, JD; Bond, PJ; Chawla, H; Crispin, M; Cunningham, AF; Faustini, SE; Jossi, SE; Lamerton, RE; Marcial-Juárez, E; McLellan, JS; Newby, ML; Richter, AG; Samsudin, F; Watanabe, Y | 1 |
| Bonifant, CL; Christodoulou, I; Markovitz, DM; Marple, AN; Rahnama, R; Ravich, JW; Seo, J; Zolov, SN | 1 |
| Bhatt, AN; Chandna, S; Chinnadurai, V; Harshan, KH; Kumar, A; Kumari, N; Rai, Y; Vedagiri, D | 1 |
| Bartenschlager, R; Bertozzi, CR; Blish, CA; Bogyo, M; Braulke, T; Carette, JE; Flynn, RA; Jabs, S; Klüssendorf, M; Mosen, PR; Nagamine, CM; Ooi, YS; Peters, CE; Puschnik, AS; Qiao, W; Richards, CM; Riley, NM; Rustagi, A; Schweizer, M; Shi, PY; Varanese, LD; Widen, JC; Winter, D; Xie, X; Zengel, JR | 1 |
| Emmett, MR; Fokt, I; Manning, JT; Matejin, S; Paessler, S; Pająk, B; Priebe, W; Zieliński, R | 1 |
| Au, WK; Cai, JP; Canena, D; Chan, CC; Chan, JF; Chan, KH; Chan, WM; Chik, KK; Chu, H; Hain, L; Hinterdorfer, P; Hou, Y; Klausberger, M; Legendre, M; Luo, C; Markovitz, DM; Moon, JJ; Oh, YJ; Oostenbrink, C; Penninger, JM; Poon, VK; Qin, Z; Seferovic, H; Shuai, H; Sit, KY; Stadlmann, J; Tampé, R; Thomas, DG; To, KK; Wang, Y; Wen, L; Xu, C; Ye, ZW; Yeung, ML; Yuan, S; Yuen, KY; Yuen, TT; Zhang, AJ; Zhu, R | 1 |
| Maier, I | 1 |
| Ahuja, A; Alvarez Canete, CA; Lampidis, T; McDonald, C; Mesri, EA; Naipauer, J; Nuñez Del Prado, Z; Schlesinger, M | 1 |
| Higashiura, A; Hirayama, M; Hori, K; Kitamura, Y; Kurokawa, H; Lawal-Ayinde, BM; Morita, T; Nakano, Y; Nazmul, T; Nomura, T; Sakaguchi, T; Yamamoto, A; Yoshimoto, R | 1 |
| Babayeva, M; Fomin, G; Petrovsky, N; Renu, S; Renukaradhya, GJ; Solomadin, M; Tabynov, K; Turebekov, N; Yadagiri, G; Yerubayev, T | 1 |
| Jin, W; Linhardt, RJ; McCandless, MG; Mitra, D; Sharma, P; Tandon, R; Zhang, F; Zhang, W | 1 |
| Barre, A; Benoist, H; Damme, EJMV; Rougé, P; Simplicien, M | 1 |
| Baker, K; Bowen, T; Byrd-Leotis, L; Cummings, RD; Lasanajak, Y; Song, X; Steinhauer, DA; Suthar, MS | 1 |
2 review(s) available for mannose and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses.
Topics: Antiviral Agents; COVID-19; Deoxyglucose; Glucose; Glycolysis; Humans; Mannose; SARS-CoV-2; Zika Virus; Zika Virus Infection | 2022 |
Man-Specific, GalNAc/T/Tn-Specific and Neu5Ac-Specific Seaweed Lectins as Glycan Probes for the SARS-CoV-2 (COVID-19) Coronavirus.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Lectins; Mannose; Pandemics; Pneumonia, Viral; Polysaccharides; SARS-CoV-2; Seaweed | 2020 |
12 other study(ies) available for mannose and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication.
Topics: Adult; Aged; Amino Acid Transport System y+; Amino Acids; Biomarkers; Blood Proteins; Carbohydrates; Case-Control Studies; COVID-19; Glucose Transporter Type 1; Hospitalization; Humans; Immunophenotyping; Mannose; Mannose-Binding Lectin; Middle Aged; SARS-CoV-2; Severity of Illness Index; Virus Replication | 2021 |
Glycosylation and Serological Reactivity of an Expression-enhanced SARS-CoV-2 Viral Spike Mimetic.
Topics: Antibodies, Viral; Binding Sites; COVID-19; Glycosylation; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Mannose; Mutation, Missense; Oligosaccharides; Polysaccharides; Proline; Recombinant Proteins; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |
Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection.
Topics: Cell Line; Cell- and Tissue-Based Therapy; COVID-19; HEK293 Cells; Humans; Immunotherapy; Killer Cells, Natural; Mannose; Musa; Plant Lectins; Receptors, Chimeric Antigen; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Viral Envelope; Viral Envelope Proteins | 2021 |
Glycolytic inhibitor 2-deoxy-d-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions.
Topics: Adenosine Triphosphate; Animals; Antiviral Agents; Cell Proliferation; Cell Survival; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Deoxyglucose; Glucose; Glycolysis; Glycosylation; Host-Pathogen Interactions; Mannose; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virion; Virus Replication | 2022 |
The human disease gene LYSET is essential for lysosomal enzyme transport and viral infection.
Topics: Animals; Cathepsins; COVID-19; Humans; Lysosomes; Mannose; Mice; Mice, Knockout; Mucolipidoses; Proteins; Transferases (Other Substituted Phosphate Groups) | 2022 |
A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo.
Topics: Angiotensin-Converting Enzyme 2; Antiviral Agents; COVID-19; Humans; Lectins; Mannose; Middle East Respiratory Syndrome Coronavirus; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |
Engineering recombinantly expressed lectin-based antiviral agents.
Topics: Acetylglucosamine; Antiviral Agents; Binding Sites; Broadly Neutralizing Antibodies; Carrier Proteins; COVID-19; Disulfides; Glycoproteins; Hemagglutinins; HIV Infections; HIV-1; Humans; Lectins; Mannose; Oligosaccharides; Peptides; Polysaccharides; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |
Glucose and mannose analogs inhibit KSHV replication by blocking N-glycosylation and inducing the unfolded protein response.
Topics: Antiviral Agents; COVID-19; Glucose; Glycosylation; Herpesvirus 8, Human; Humans; Mannose; Sarcoma, Kaposi; Unfolded Protein Response; Virus Replication | 2023 |
Capture and neutralization of SARS-CoV-2 and influenza virus by algae-derived lectins with high-mannose and core fucose specificities.
Topics: COVID-19; Fucose; Humans; Lectins; Mannose; Mannose-Binding Lectins; Orthomyxoviridae; Polysaccharides; SARS-CoV-2 | 2023 |
An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters.
Topics: Adjuvants, Immunologic; Aluminum Hydroxide; Animals; Antibodies, Neutralizing; Antibodies, Viral; Chitosan; COVID-19; COVID-19 Vaccines; Cricetinae; Mannose; Mesocricetus; Mice; Mice, Inbred BALB C; Nanoparticles; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccines | 2023 |
The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica.
Topics: Angiotensin-Converting Enzyme 2; Betacoronavirus; Binding Sites; Coronavirus Infections; COVID-19; Glucuronates; Heparin; Humans; Mannose; Oligosaccharides; Pandemics; Peptidyl-Dipeptidase A; Phaeophyceae; Pneumonia, Viral; Polysaccharides; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship | 2020 |
SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung.
Topics: Animals; Cattle; COVID-19; Host Microbial Interactions; Humans; Lung; Mannose; Middle East Respiratory Syndrome Coronavirus; N-Acetylneuraminic Acid; Phosphorylation; Polysaccharides; Protein Array Analysis; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2021 |